The MASAI trial reveals AI in mammography increases cancer detection by 29% and decreases radiologists' workload by 44%, ...
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...
As cancer rates in the West, and globally, tack upwards due to lifestyle and environmental pollution, so does the need for ...
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.
A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using ...
The FDA has approved a companion diagnostic to determine if patients with HR-positive, HER2-ultralow metastatic breast cancer are eligible for T-DXd treatment.